Who is sponsoring NCT06077253?

NCT06077253 is sponsored by University of Aarhus.

What drugs are being tested in NCT06077253?

Interventions in NCT06077253: Iridotomy.

What condition does NCT06077253 study?

NCT06077253 studies Primary Angle Glaucoma Closure Suspect.

Is NCT06077253 still recruiting?

NCT06077253 is currently recruiting now. Last updated 13 November 2023.

Last reviewed 2023-11-13 · How we verify

NCT06077253: DAP

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Danish Angle Closure Prevention Trial

Recruiting now NA Last updated 13 November 2023

What this trial tests

NA trial testing Iridotomy in Primary Angle Glaucoma Closure Suspect in 242 participants. Currently enrolling.

Timeline

1 September 2023

Primary endpoint
1 September 2029

1 September 2029

Quick facts

Lead sponsor	University of Aarhus
Phase	NA
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	randomized
Design	single group
Masking	none
Primary purpose	prevention
Enrollment	242
Start date	1 September 2023
Primary completion	1 September 2029
Estimated completion	1 September 2029
Sites	5 locations across Denmark

Drugs / interventions tested

Iridotomy

Conditions studied

Primary Angle Glaucoma Closure Suspect — all drugs for Primary Angle Glaucoma Closure Suspect →

Sponsor

University of Aarhus

Who can join

Adults 40 to 80, any sex, with Primary Angle Glaucoma Closure Suspect. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To determine whether primary angle closure suspects (PACS) in a Caucasian population benefit from prophylactic laser iridotomy.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other University of Aarhus trials

Trials by the same sponsor.

NCT07209540 — European LUpuS Inception-Cohort Developing initiATivE · not yet recruiting
NCT07317401 — Investigating the Effects of Intermittent Hypoxia-Hyperoxia Treatment (IHHT) in People With Post-Viral Myalgic Encephalo · NA · not yet recruiting
NCT07531966 — Vascular Complications After Kidney Transplantation · recruiting
NCT07528339 — Prospective RegIstry for Oncologic Reirradiation (PRIOR-DK) · not yet recruiting
NCT07451028 — Effect of an Oral Neuromuscular Training Device on Dysphagia · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06077253 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Aarhus
Last refreshed: 13 November 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06077253.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing